EverydayHealthLogo
KN

Dr. Kari Nadeau, MD, PHD

Boston, MA

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Nadeau, Allergist & Immunologist in Boston, MA?

    Dr. Kari Nadeau, MD, PHD is an Allergist & Immunologist, who primarily practices in Boston, MA with 1 additional practice location. She is board certified. Dr. Nadeau graduated from Harvard Medical School, Boston, Massachusetts and completed her residency at Children's Hospital Program. Dr. Nadeau is fluent in English and Spanish, and is currently seeing new patients. Dr. Nadeau’s practice accepts Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Nadeau’s office at (617) 632-0766.

    What are Areas of Expertise for Dr. Nadeau?

    Dr. Kari Nadeau, MD, PHD is a highly-rated, board-certified Allergist & Immunologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Nadeau empowers patients to confidently navigate their health journey, specializing in Allergy, Asthma, Clinical Trials, and comprehensive wellness support. Serving the Boston, MA community, Dr. Nadeau is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Nadeau go to medical school and complete their residency?

    • Residency: Children's Hospital Program

    • Medical School: Harvard Medical School, Boston, Massachusetts | Harvard Medical School, Boston, Massachusetts

    Is Dr. Nadeau board certified as an Allergist & Immunologist?

    Yes, Dr. Kari Nadeau, MD, PHD is board certified by the American Board of Allergy and Immunology , American Board of Pediatrics

    What languages does Dr. Nadeau speak?

    Dr. Nadeau and their clinical team can communicate with patients in the following languages:

    • English
    • Spanish

    What conditions does an Allergist & Immunologist like Dr. Nadeau typically treat?

    As an Allergist & Immunologist, Dr. Nadeau diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Nadeau. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.

    Also known as:

    • Hay Fever
    • Pollen allergy
    • Seasonal allergies
    • Allergic rhinitis

    ICD-10 Codes:

    • J301: Allergic rhinitis due to pollen

    Also known as:

    • Allergy
    • Allergic Reaction
    • Hypersensitivity
    • Allergic Condition

    ICD-10 Codes:

    • T7840XA: Allergy, unspecified, initial encounter

    Also known as:

    • Other Food Allergy
    • Food Allergy
    • Unspecified Food Allergy
    • Multiple Food Allergies
    • Food Hypersensitivity

    ICD-10 Codes:

    • Z91018: Allergy to other foods

    Also known as:

    • Unspecified drug allergy
    • Drug Reactions
    • Allergy to unknown medication
    • Drug hypersensitivity
    • Adverse reaction to medication

    ICD-10 Codes:

    • Z889: Allergy status to unspecified drugs, medicaments and biological substances

    What procedures does an Allergist & Immunologist like Dr. Nadeau typically perform?

    As an Allergist & Immunologist, procedures performed by Dr. Kari Nadeau may include:

    Please contact Dr. Nadeau's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.

    Does Dr. Nadeau accept my insurance?

    Dr. Nadeau accepts most major insurance plans. Important: Please call our office at (617) 632-0766 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Nadeau accept in Boston, MA?

    Dr. Nadeau in Boston, MA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • CVS Health (formerly Aetna)

    • Medicare

    • Other TPA

    • Point32Health

    View All Insurances

    Where is Dr. Nadeau's office located?

    Dr. Kari Nadeau's Primary Practice

    330 Brookline Ave

    Boston, MA 02215

    (617) 632-0766

    Get Directions

    Dr. Kari Nadeau's Practice 2

    110 Francis St Ste Gb

    Boston, MA 02215

    Get Directions

    What hospitals are Dr. Nadeau affiliated with?

    CastleConnolyTopDoctors

    Castle Connolly Top Hospital

    This doctor is affiliated with a Castle Connolly Top Hospital.

    Dr. Nadeau has admitting privileges at the following hospitals:

    Stanford Medicine Children’s Health,Palo Alto, CA

    Recognitions

    Publications

    • Whole-exome sequencing identifies tetratricopeptide repeat domain 7A, 2013

    • Differentiating the roles of STAT5B and STAT5A in human CD4(+) T cells, 2013

    • Markers of Antigen Presentation and Activation on Eosinophils and T Cells, 2013

    • Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease, 2013

    • Asthma Discordance in Twins Is Linked to Epigenetic Modifications of T Cells, 2012

    • Epigenetic modifications, 2012

    • Modulation of mTOR Effector Phosphoproteins in Blood Basophils from Allergic Patients, 2012

    • Persol Omics Profiling Reveals Dymic Molecular and Medical Phenotypes, 2012

    • Multiplex meta-alysis of R expression to identify genes with variants associated with immune, 2012

    • Oral Immunotherapy and Anti-IgE Antibody-Adjunctive Treatment for Food Allergy, 2012

    • The STAT5b Pathway Defect and Autoimmunity., 2012

    • The Safety of Peanut Oral Immunotherapy in Peanut-Allergic Subjects in a Single-Center Trial, 2012

    • Genotype, phenotype, and outcomes of nine patients with T-B plus NK plus SCID, 2011

    • T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell, 2011

    • Immunophenotyping of Peripheral Eosinophils Demonstrates Activation in Eosinophilic Esophagitis, 2011

    • Rapid oral desensitization in combition with omalizumab therapy in patients with cow's milk allergy, 2011

    • STAT5b Deficiency: An Unsuspected Cause of Growth Failure, Immunodeficiency, 2011

    • Basophil CD203c Levels Are Increased at Baseline, 2011

    • Migration of regulatory T cells toward airway epithelial cells is impaired, 2010

    • Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene, 2010

    • Bradykinin Inhibitors in Hereditary Angioedema, 2010

    • Ambient Air Pollution Impairs Regulatory T-Cell Function in Asthma., 2010

    • Increased Number of Regulatory T Cells in Children with Eosinophilic Esophagitis., 2010

    • Epoprostenol-Associated Pneumonitis: Diagnostic Use of a T Cell Proliferation Assay, 2010

    • Increased HLA-DR Expression on Tissue Eosinophils in Eosinophilic Esophagitis., 2010

    • TSLP directly impairs pulmory Treg function, 2010

    • Eotaxin and FGF enhance sigling through an extracellular sigl-related kise, 2010

    • Measurement and Clinical Monitoring of Human Lymphocyte Clolity by Massively Parallel V-D, 2009

    • Impaired IL-10-dependent Induction of Tolerogenic Dendritic Cells by CD4(+)CD25(hi)CD127(lo, 2009

    • Neotal Alloimmune Thrombocytopenia, 2009

    • Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by, 2009

    • Selective deregulation in chemokine sigling pathways of CD4(+)CD25(hi)CD127(lo, 2009

    • T Lymphocytes and Its Subsets in Transplanted Small Bowel Treated with Alemtuzumab (Campath-1H), 2009

    • Idiopathic neutropenia of childhood is associated with Fas/FasL expression, 2008

    • XCL1 enhances regulatory activities of CD4(+)CD25(high)CD127(low, 2008

    • Increased cytotoxicity of CD4(+) invariant NKT cells against CD4(+)CD25(hi)CD127(lo, 2008

    • A novel mutation associated with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, 2008

    • Altered phosphorylated sigl transducer, 2007

    • Cutting edge: Decreased accumulation and regulatory function of CD4(+)CD25(high) T cells in human, 2006

    • Lgl1 is suppressed in oxygen toxicity animal models of bronchopulmory dysplasia, 2006

    • Successful conversion from conventiol immunosuppression to anti, 2001

    • Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors., 2000

    • Rel allograft protection with losartan in Fisher -> Lewis rats: Hemodymics, macrophages, 2000

    • Cloning and characterization of the two enzymes responsible for trypanothione biosynthesis in, 1998

    • Effects of explosive brain death on cytokine activation of peripheral organs in the rat, 1998

    • Late blockade of T cell costimulation interrupts progression of experimental chronic allograft, 1998

    • Influence of initial antigen-independent events on acute allograft rejection, 1998

    • Infection-associated macrophage activation accelerates chronic rel allograft rejection in rats, 1997

    • Prevention of late rel changes after initial ischemia, 1997

    • CD28-B7 blockade in organ dysfunction secondary to cold ischemia, 1997

    • The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury, 1997

    • Cellular and molecular predictors of chronic rel dysfunction after initial ischemia, 1997

    • The cytokine-adhesion molecule cascade in ischemia, 1997

    • Sequential cellular and molecular kinetics in acutely rejecting rel allografts in rats, 1997

    • Uccompanied children in detention in the US, 1997

    • Immigrating uccompanied miners - A neglected minority?, 1997

    • Nephron mass modulates the hemodymic, cellular, and molecular response of the rat rel allograft, 1997

    • Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine, 1997

    • Initial ischemia/reperfusion injury influences late functiol and structural changes in the kidney, 1997

    • Early cellular and molecular changes in ischemia, 1997

    • Sequential cytokine expression in rel allografts in rats immunosuppressed with maintence, 1996

    • Blockade of T-cell costimulation prevents development of experimental chronic rel allograft, 1996

    • Inflammatory mediators, cells and their products in acute host alloresponsiveness., 1996

    • Prevention of functiol, structural, 1995

    • SEQUENTIAL CYTOKINE DYMICS IN CHRONIC REJECTION OF RAT REL-ALLOGRAFTS, 1995

    • QUANTITATION OF THE INTERACTION OF THE IMMUNOSUPPRESSANT DEOXYSPERGUALIN AND ALOGS WITH HSC70 AND HS, 1994

    • MOLECULAR AND BIOCHEMICAL-COMPARISON OF THE 70-KDA HEAT-SHOCK PROTEINS OF TRYPANOSOMA-CRUZI, 1994

    • HSP90 CHAPERONINS POSSESS ATPASE ACTIVITY AND BIND HEAT, 1993

    • STUDIES ON THE INTERACTION OF THE IMMUNOSUPPRESSANT 15-DEOXYSPERGUALIN WITH HEAT-SHOCK PROTEINS, 1993

    • 83-KILODALTON HEAT-SHOCK PROTEINS OF TRYPANOSOMES ARE POTENT PEPTIDE-STIMULATED ATPASES, 1992

    • KINETIC ISOTOPE EFFECT ALYSIS OF THE REACTION CATALYZED BY TRYPANOSOMA, 1992

    • PURIFICATION OF GLUTATHIONYLSPERMIDINE AND TRYPANOTHIONE SYNTHETASES FROM CRITHIDIA-FASCICULATA, 1992

    • MOLECULAR STUDIES ON TRYPANOTHIONE REDUCTASE - AN ANTIPARASITIC TARGET ENZYME, 1992

    • MOLECULAR STUDIES ON TRYPANOTHIONE REDUCTASE, A TARGET FOR ANTIPARASITIC DRUGS, 1991

    • A TEST FOR GENETIC EXCHANGE IN MIXED INFECTIONS OF LEISHMANIA-MAJOR IN THE SAND FLY PHLEBOTOMUS, 1991

    • THE PROMOTER OF THE LATENCY-ASSOCIATED TRANSCRIPTS OF HERPES, 1991

    What is Dr. Nadeau's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Nadeau's National Provider Identifier (NPI) number is 1871652644.

    What common questions do patients ask about Dr. Nadeau?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Nadeau

    What is Dr. Kari Nadeau's specialty?

    What does an Allergist & Immunologist do?

    An allergist-immunologist is well-versed in the assessment, physical examination, laboratory diagnosis, and treatment of immune system disorders. These conditions include, but are not limited to, eczema, asthma, anaphylaxis, rhinitis, and adverse reactions to food, medication, and insect stings. Furthermore, they manage immune deficiency diseases, whether acquired or congenital, issues with host defense, and challenges associated with autoimmune diseases, organ transplantation, or immune system malignancies.

    Is Dr. Kari Nadeau affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Nadeau is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    When to see an Allergist & Immunologist?: Guides for symptoms, conditions, and treatments

    Understand your symptoms and know when it’s time to see an Allergist & Immunologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Dr. Kari Nadeau accepting new patients in Boston, MA?

    Yes, Dr. Kari Nadeau is accepting new patients at this time.

    Does Dr. Kari Nadeau offer online booking?

    Please contact Dr. Nadeau's office at (617) 632-0766 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Dr. Kari Nadeau?

    Please contact Dr. Nadeau's office at (617) 632-0766 to schedule an appointment.

    Where is Dr. Nadeau's office located?

    Dr. Nadeau's office is located in Boston, MA.

    Which board certifications does Dr. Kari Nadeau have?

    Dr. Kari Nadeau is certified by the American Board of Allergy and Immunology and American Board of Pediatrics.